tirzepatide news update Compounded versions of (Mounjaro, Zepbound) containing vitamin B12 pose a potential safety risk to the public, Eli Lilly warned in an open letter on Thursday. Following laboratory testing, the drugmaker said 2026 FDA Rules and News

Symptoms of low calcium include numbness or tingling in fingers and toes, muscle aches , cramps, and in severe cases, confusion or memory problems

Simultaneously, tirzepatide suppresses inappropriate glucagon secretion from pancreatic alpha cells, which helps prevent excessive hepatic glucose production

PubMed Duzel, A., Vlainic, J., Antunovic, M., Malekinusic, D., Vrdoljak, B., Samara, M., Gojkovic, S., Krezic, I., Vidovic, T., Bilic, Z., Sjekavica, I., Djuzel, A.R., Knezevic, M., Sever, A.Z., Lojo, N., Kokot, A., Sever, M., Drmic, D., Seiwerth, S., Sikiric, P

Market Restraint High Cost of GLP-1-Based Weight Loss Medications The high cost of GLP-1 receptor agonists for obesity management is a major restraint limiting their widespread adoption